127 related articles for article (PubMed ID: 14728639)
1. The effect of short-term estradiol therapy on cognitive function in older men receiving hormonal suppression therapy for prostate cancer.
Taxel P; Stevens MC; Trahiotis M; Zimmerman J; Kaplan RF
J Am Geriatr Soc; 2004 Feb; 52(2):269-73. PubMed ID: 14728639
[TBL] [Abstract][Full Text] [Related]
2. The effect of short-term estradiol therapy on clotting and inflammatory markers in older men receiving hormonal suppression therapy for prostate cancer.
Taxel P; Luthra P; Fall PM; Dauser D
Aging Male; 2008 Jun; 11(2):71-5. PubMed ID: 18570058
[TBL] [Abstract][Full Text] [Related]
3. A randomized controlled trial of add-back estrogen or placebo on cognition in men with prostate cancer receiving an antiandrogen and a gonadotropin-releasing hormone analog.
Matousek RH; Sherwin BB
Psychoneuroendocrinology; 2010 Feb; 35(2):215-25. PubMed ID: 19615826
[TBL] [Abstract][Full Text] [Related]
4. The effect of micronized estradiol on bone turnover and calciotropic hormones in older men receiving hormonal suppression therapy for prostate cancer.
Taxel P; Fall PM; Albertsen PC; Dowsett RD; Trahiotis M; Zimmerman J; Ohannessian C; Raisz LG
J Clin Endocrinol Metab; 2002 Nov; 87(11):4907-13. PubMed ID: 12414849
[TBL] [Abstract][Full Text] [Related]
5. Cognition is not modified by large but temporary changes in sex hormones in men.
Young LA; Neiss MB; Samuels MH; Roselli CE; Janowsky JS
J Clin Endocrinol Metab; 2010 Jan; 95(1):280-8. PubMed ID: 19880786
[TBL] [Abstract][Full Text] [Related]
6. Does neoadjuvant hormone therapy for early prostate cancer affect cognition? Results from a pilot study.
Jenkins VA; Bloomfield DJ; Shilling VM; Edginton TL
BJU Int; 2005 Jul; 96(1):48-53. PubMed ID: 15963119
[TBL] [Abstract][Full Text] [Related]
7. The effect of low dose micronized 17ss-estradiol on bone turnover, sex hormone levels, and side effects in older women: a randomized, double blind, placebo-controlled study.
Prestwood KM; Kenny AM; Unson C; Kulldorff M
J Clin Endocrinol Metab; 2000 Dec; 85(12):4462-9. PubMed ID: 11134094
[TBL] [Abstract][Full Text] [Related]
8. Cognitive impairment in men treated with luteinizing hormone-releasing hormone agonists for prostate cancer: a controlled comparison.
Jim HS; Small BJ; Patterson S; Salup R; Jacobsen PB
Support Care Cancer; 2010 Jan; 18(1):21-7. PubMed ID: 19343369
[TBL] [Abstract][Full Text] [Related]
9. Ultralow-dose micronized 17beta-estradiol and bone density and bone metabolism in older women: a randomized controlled trial.
Prestwood KM; Kenny AM; Kleppinger A; Kulldorff M
JAMA; 2003 Aug; 290(8):1042-8. PubMed ID: 12941676
[TBL] [Abstract][Full Text] [Related]
10. The effect of 3-year treatment with 0.25 mg/day of micronized 17beta-estradiol on cognitive function in older postmenopausal women.
Pefanco MA; Kenny AM; Kaplan RF; Kuchel G; Walsh S; Kleppinger A; Prestwood K
J Am Geriatr Soc; 2007 Mar; 55(3):426-31. PubMed ID: 17341247
[TBL] [Abstract][Full Text] [Related]
11. One year follow-up study of the association between chemical castration, sex hormones, beta-amyloid, memory and depression in men.
Almeida OP; Waterreus A; Spry N; Flicker L; Martins RN
Psychoneuroendocrinology; 2004 Sep; 29(8):1071-81. PubMed ID: 15219659
[TBL] [Abstract][Full Text] [Related]
12. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.
Rapp SR; Espeland MA; Shumaker SA; Henderson VW; Brunner RL; Manson JE; Gass ML; Stefanick ML; Lane DS; Hays J; Johnson KC; Coker LH; Dailey M; Bowen D;
JAMA; 2003 May; 289(20):2663-72. PubMed ID: 12771113
[TBL] [Abstract][Full Text] [Related]
13. Altered cognitive function in men treated for prostate cancer with luteinizing hormone-releasing hormone analogues and cyproterone acetate: a randomized controlled trial.
Green HJ; Pakenham KI; Headley BC; Yaxley J; Nicol DL; Mactaggart PN; Swanson C; Watson RB; Gardiner RA
BJU Int; 2002 Sep; 90(4):427-32. PubMed ID: 12175403
[TBL] [Abstract][Full Text] [Related]
14. Exogenous testosterone alone or with finasteride does not improve measurements of cognition in healthy older men with low serum testosterone.
Vaughan C; Goldstein FC; Tenover JL
J Androl; 2007; 28(6):875-82. PubMed ID: 17609296
[TBL] [Abstract][Full Text] [Related]
15. Randomized controlled trial of annual zoledronic acid to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer.
Michaelson MD; Kaufman DS; Lee H; McGovern FJ; Kantoff PW; Fallon MA; Finkelstein JS; Smith MR
J Clin Oncol; 2007 Mar; 25(9):1038-42. PubMed ID: 17369566
[TBL] [Abstract][Full Text] [Related]
16. The antiosteoporotic efficacy of intravenous pamidronate in men with prostate carcinoma receiving combined androgen blockade: a double blind, randomized, placebo-controlled crossover study.
Diamond TH; Winters J; Smith A; De Souza P; Kersley JH; Lynch WJ; Bryant C
Cancer; 2001 Sep; 92(6):1444-50. PubMed ID: 11745221
[TBL] [Abstract][Full Text] [Related]
17. Cognitive function in association with sex hormones in postmenopausal women.
Kocoska-Maras L; Rådestad AF; Carlström K; Bäckström T; von Schoultz B; Hirschberg AL
Gynecol Endocrinol; 2013 Jan; 29(1):59-62. PubMed ID: 22967437
[TBL] [Abstract][Full Text] [Related]
18. The effects of 3-week estrogen hormone replacement on cognition in elderly healthy females.
Duka T; Tasker R; McGowan JF
Psychopharmacology (Berl); 2000 Apr; 149(2):129-39. PubMed ID: 10805607
[TBL] [Abstract][Full Text] [Related]
19. Incomplete testosterone suppression with luteinizing hormone-releasing hormone agonists: does it happen and does it matter?
Pickles T; Hamm J; Morris WJ; Schreiber WE; Tyldesley S
BJU Int; 2012 Dec; 110(11 Pt B):E500-7. PubMed ID: 22564197
[TBL] [Abstract][Full Text] [Related]
20. Cognitive Function in Patients With Prostate Cancer Receiving Luteinizing Hormone-Releasing Hormone Analogues: A Prospective, Observational, Multicenter Study.
Morote J; Tabernero ÁJ; Álvarez Ossorio JL; Ciria JP; Domínguez-Escrig JL; Vázquez F; Angulo J; López FJ; de La Iglesia R; Romero J;
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):590-594. PubMed ID: 28581399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
